Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Carboplatin × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 123 Lung Neoplasms 49 Squamous Cell Carcinoma of Head and Neck 32 Triple Negative Breast Neoplasms 29 Breast Neoplasms 28 Ovarian Neoplasms 25 Small Cell Lung Carcinoma 21 Neoplasm Metastasis 19 Fallopian Tube Neoplasms 19 Endometrial Neoplasms 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 15 Neoplasms 13 Head and Neck Neoplasms 13 Colorectal Neoplasms 12 Oropharyngeal Neoplasms 11 Carcinoma, Squamous Cell 11 Prostatic Neoplasms 10 Esophageal Neoplasms 10 Carcinoma, Transitional Cell 10 Carcinoma 10 Urinary Bladder Neoplasms 9 Laryngeal Neoplasms 9 Mouth Neoplasms 8 Uterine Cervical Neoplasms 7 Pancreatic Neoplasms 7 Stomach Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Recurrence 5 Brain Neoplasms 5 Adenocarcinoma of Lung 5

Interventions

fludarabine 4 Cyclophosphamide 4 blinatumomab 3 Melphalan 3 pembrolizumab 2 fludarabine phosphate 2 Lenalidomide 2 Dexamethasone 2 Cytarabine 2 Capecitabine 2 venetoclax 1 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 palbociclib 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 avelumab 1 abemaciclib 1 Whole-Body Irradiation 1 Trastuzumab 1 Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡